Emd Serono Research & Development Institute, Inc.

This early-phase study tested a new drug called M6223, which targets the immune system to fight cancer. It was given alone or with another drug (bintrafusp alfa) to 58 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check…

This study gave 22 cancer patients ongoing access to the drug bintrafusp alfa after they completed earlier trials. Researchers tracked side effects and survival for up to 5 years to understand the drug's long-term safety and effectiveness. The goal was to keep treating patients w…

This study tested cladribine tablets in 291 adults with relapsing forms of multiple sclerosis (MS) who had not done well on other oral or infusion medications. The goal was to see if switching to cladribine could reduce relapses and improve patient satisfaction. Results showed ho…

This study tested an experimental pill called enpatoran in 456 adults with lupus (SLE) or lupus affecting the skin (CLE). Participants took the drug or a placebo for 24 weeks while continuing their usual treatments. The goal was to see if enpatoran safely reduces skin rashes and …

This study tested whether a new liquid form of follitropin alfa (a hormone used for fertility) works the same as the older powder form. Fifty-five healthy men received both versions in a random order. The goal was to check if the new form is equivalent, not to treat any disease.